Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP473021.RA1SN4Q9nJM-XN2tHtitodxnFekmmuE98JVCEAKeDD1MM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP473021.RA1SN4Q9nJM-XN2tHtitodxnFekmmuE98JVCEAKeDD1MM130_assertion type Assertion NP473021.RA1SN4Q9nJM-XN2tHtitodxnFekmmuE98JVCEAKeDD1MM130_head.
- NP473021.RA1SN4Q9nJM-XN2tHtitodxnFekmmuE98JVCEAKeDD1MM130_assertion description "[The myotonic disorders, including the myotonic dystrophies (myotonic dystrophy type 1, DM1; myotonic dystrophy type 2, DM2/PROMM/PDM), the muscle channelopathies or non-dystrophic myotonias (chloride, sodium, calcium and potassium channelopathies) are all characterized by myotonia and muscle weakness despite different pathophysiology involved in these disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP473021.RA1SN4Q9nJM-XN2tHtitodxnFekmmuE98JVCEAKeDD1MM130_provenance.
- NP473021.RA1SN4Q9nJM-XN2tHtitodxnFekmmuE98JVCEAKeDD1MM130_assertion evidence source_evidence_literature NP473021.RA1SN4Q9nJM-XN2tHtitodxnFekmmuE98JVCEAKeDD1MM130_provenance.
- NP473021.RA1SN4Q9nJM-XN2tHtitodxnFekmmuE98JVCEAKeDD1MM130_assertion SIO_000772 15269662 NP473021.RA1SN4Q9nJM-XN2tHtitodxnFekmmuE98JVCEAKeDD1MM130_provenance.
- NP473021.RA1SN4Q9nJM-XN2tHtitodxnFekmmuE98JVCEAKeDD1MM130_assertion wasDerivedFrom befree-20140225 NP473021.RA1SN4Q9nJM-XN2tHtitodxnFekmmuE98JVCEAKeDD1MM130_provenance.
- NP473021.RA1SN4Q9nJM-XN2tHtitodxnFekmmuE98JVCEAKeDD1MM130_assertion wasGeneratedBy ECO_0000203 NP473021.RA1SN4Q9nJM-XN2tHtitodxnFekmmuE98JVCEAKeDD1MM130_provenance.